Dr. Andrew Gregory Mitton, M.D. Psychiatry & Neurology - Vascular Neurology Medicare: Accepting Medicare Assignments Practice Location: 23815 Stuart Ranch Rd Ste 300, Malibu, CA 90265 Phone: 310-456-1668 |
Adrian Finkelstein, M.D. Psychiatry & Neurology - Psychosomatic Medicine Medicare: May Accept Medicare Assignments Practice Location: 22837 Pacific Coast Hwy, Suite B, Malibu, CA 90265 Phone: 310-918-7413 Fax: 310-457-3790 |
Robert M. Bunes, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 229 Lorine Ln, Malibu, CA 90265 Phone: 310-317-0408 |
Dr. Bruce Lockwood, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 23712 Malibu Rd, Malibu, CA 90265 Phone: 310-456-1725 Fax: 310-456-9772 |
Litos O. Mallare, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 23823 Malibu Rd, Suite 50, #189, Malibu, CA 90265 Phone: 310-650-8951 Fax: 310-457-1082 |
Stuart A Lerner, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3721 Oceanhill Way, Malibu, CA 90265 Phone: 310-459-8264 |
News Archive
GE Healthcare, a business unit of General Electric Company, announced today a commitment to reduce the average energy consumption of new ultrasound products by 25 percent by 2012.
A controversial new Indiana law limiting access to abortion services remains in effect after a federal judge Wednesday denied a request for a restraining order from Planned Parenthood. The brief ruling from Judge Tanya Walton Pratt in Indianapolis means the law signed hours earlier by Gov. Mitch Daniels, a potential 2012 Republican presidential candidate, can continue to be enforced.
A rare, short-lived population of immune cells in the bloodstream may serve as 'periscopes' to monitor immune status via lymph nodes deep inside the body, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.
Generex Biotechnology Corporation announced today that the first patients had received a novel therapeutic vaccine developed by its wholly owned subsidiary, Antigen Express as part of the Company's Phase I Trial. The Trial will include between 16 and 24 patients.
› Verified 7 days ago